There is increasing recognition among CMS and commercial insurers that mental health is the ideal launching pad for virtual ...

Sage Therapeutics reported that Biogen made an unsolicited offer to purchase all of the shares of the biopharmaceutical firm it doesn't already own.

Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions BOSTON, Jan. 10, 2025 /PRNewswire/ -- According ...

Patient-focused digital therapeutics that focus on specific diseases are enabling more patients to receive treatment at home and can now access more approvals and reimbursement pathways that offer ...

The health and technology sectors intersected in fresh ways in 2024, marking a transformation largely driven by the increased ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the US Food and ...

LAS VEGAS, NV / ACCESSWIRE / / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events ...

AbbVie said it would take a $3.5 billion dollar impairment charge related to the failure of a drug it acquired in its ...

Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...

Digital mental health platforms were supposed to expand access for the neediest patients. Researchers say that hasn’t ...

140 prescription digital therapeutics are approved for patient use at home and more than 220 therapies are used within digital care or in clinics. Sensor-based digital biomarkers that track ...

In an era where chronic health conditions affect millions worldwide, Ron Elul, Founder and CEO of Curalife, is pioneering a ...